High Court Preemption Ruling Would Hit Branded Cos. Hard

Law360, New York (May 23, 2011, 1:36 PM EDT) -- If the U.S. Supreme Court finds that generic-drug makers are not liable for state failure-to-warn claims in a case alleging that federal regulations shield generics makers from such allegations, lawsuits against the drugs' original manufacturers will increase as plaintiffs with diminished options search for a party to blame for their injuries, attorneys say.

The Supreme Court held oral arguments on March 30 in a trio of consolidated appeals in which the high court will determine whether its 2009 landmark decision in Wyeth v. Levine, which held...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.